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Abstract 
The average age of women at childbirth in industrialised nations has been increasing steadily 
for approximately 30 years.  Women aged 35 years or over have an increased risk of 
gestational hypertensive disease, gestational diabetes, placenta praevia, placental abruption, 
perinatal death, preterm labour, fetal macrosomia and fetal growth restriction.  
Unsurprisingly, rates of obstetric intervention are higher among older women.  Of particular 
concern is the increased risk of antepartum stillbirth at term in women of advanced maternal 
age.  In all maternal age groups, the risk of stillbirth is higher among nulliparous women than 
among multiparous women.  Women of advanced maternal age (>40 years) should be given 
low dose aspirin (in the presence of an additional risk factor for pre-eclampsia) and offered 
serial ultrasounds for fetal growth and wellbeing; given the increased risk of antepartum 
stillbirth, induction of labour from 39 weeks’ gestation should be discussed with the woman. 
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Epidemiology 
The average age at childbirth in the UK is increasing, and more women are giving birth over 
the age of 35 years.  In 1996, 12% of live births were to women over the age of 35 years, by 
2006 that figure had risen to 20% and by 2017 it had further risen to 23%.  The Office of 
National Statistics estimated that in 2006, 4.6% of live births were to nulliparous women aged 
between 35 and 39 years of age and 0.9% were to women over the age of 40, by 2017, 6.4% 
of livebirths were to nulliparous women between 35 and 39 years of age and 1.2% were to 
women 40 years and older. 
The reasons for delaying childbirth are complex and multi-factorial and it is important to 
remember that while some women may make a conscious choice to delay childbearing, it may 
be the unwelcome sequelae of subfertility for others. 
 
Antenatal effects  
Maternal 
Women over 35 years are at higher risk of many pregnancy complications.  Is this simply 
because women over 35 years are also more likely to have pre-existing medical conditions 
than their younger counterparts, pre-disposing them to developing pregnancy complications?  
In a large prospective cohort study of over 1.5 million deliveries during a 15 year period in 
Sweden, Jacobsson et al examined the relationship between advanced maternal age (AMA) 
and adverse perinatal and obstetric outcomes, and what contribution pre-existing maternal 
medical conditions had on the occurrence of adverse outcomes in women over 40 years of 
age.  The study observed that women over 40 years of age were at increased risk of pregnancy 
complications and this risk persisted when the data was adjusted for pre-existing maternal 
disease. 
A retrospective observational study of over 150,000 deliveries in Canada considered the 
relationship between maternal age and adverse outcomes and adjusted for potential 
confounders, including pre-existing maternal medical disease.  A smaller retrospective study 
of 630 women in Italy examined the relationship between maternal age and pregnancy 
complications but did not adjust for pre-existing maternal disease.  Both of these studies 
found that pre-existing maternal disease was more common with advancing maternal age. 
Women over 40 years have a higher risk of developing gestational diabetes than women aged 
20-30 years of age (OR 3.4).   
There is some controversy over whether women of AMA are at increased risk of hypertensive 
disorders in pregnancy.  In the previously mentioned Swedish cohort study, women over 40 
years of age were found to have a higher risk of developing pregnancy-induced hypertension 
and severe pre-eclampsia, although they were at a slightly lower risk of developing mild pre-
eclampsia.  The increased risk of severe pre-eclampsia and pre-eclampsia as a whole were 
increased when the data was adjusted for pre-existing maternal disease and smoking.  There 
was an increased risk of hypertensive disorders (including pregnancy-induced hypertension 
and pre-eclampsia) in the Canadian study, after adjusting for pre-existing maternal disease in 
women over 35 years of age (adjusted rate ratio 2.32) and in women over 40 years of age 
(adjusted rate ratio 3.55). No relationship between maternal age and hypertensive disorders 
was found in the Italian study, perhaps owing to the smaller sample size. 
Women over 40 years of age are at higher risk of placenta praevia (OR 4.6 - 5.8) and placental 
abruption (adjusted rate ratio 1.8). 
A national, population-based cohort study using the UK Obstetric Surveillance System 
(UKOSS) published in 2016, reported on the outcomes for women giving birth aged ≥ 48 years.  
They found that when the data was adjusted for confounders, women were more at risk of 
gestational diabetes (AOR 4.81; 95% CI 1.93 – 12); caesarean section (AOR 2.78; 95% CI 1.44 
– 5.37) and admission to an intensive care unit (AOR 33.53; 95% CI 2.73 – 412). 
Fetal  
The pregnancies of women over 35 years are at higher risk of perinatal death; this 
encompasses antepartum and intrapartum stillbirth and early neonatal death. 
The Centre for Maternal and Child Enquiries (CMACE) report that perinatal deaths from 24-
41 completed weeks’ gestation affect 0.8% of all pregnancies to women over the age of 35 
years, and 1% of all pregnancies to women over the age of 40 years.   The distribution of 
maternal age among the mothers having perinatal deaths is significantly higher than the 
general maternity population.  Mothers having stillbirths and neonatal deaths are more likely 
to be older (40+ years).   
Women of advanced maternal age are at increased risk of preterm labour, both at less than 
32 weeks’ gestation (ARR 1.36 for women over 35 and ARR 2.41 for women over 40) and at 
less than 37 weeks’ gestation (ARR 1.61 for women over 35 and ARR 1.8 for women over 40).  
Women of AMA are at increased risk of bearing a low birth weight infant (<2500g).     
Conversely women of AMA are also at increased risk of bearing a macrosomic (>3999g) infant 
and the potential complications associated with macrosomia.  
Interestingly, it has been reported that women over 35 years of age typically believe that their 
age puts their infant at increased risk.   
 
Late pregnancy/intrapartum complications 
Obstetric intervention 
The overall Caesarean rate for nulliparous women less than 35, 35-39 and > 40 years old is 
21%, 38% and 50% respectively.  The caesarean rate for nulliparous women in labour (both 
spontaneous and induced) at term, excluding breech presentation, is 22.8% among women 
35-39 years of age and 27.4% among women aged 40 years or older (unpublished data, 
Scottish maternities 2004-2008).   In nulliparous women, the relationship between maternal 
age and delivery by emergency Caesarean is linear, which suggests a biological effect of 
advancing maternal age on labour performance, rather than simply obstetrician or maternal 
preference.  Smith et al investigated this possible biological effect of advancing maternal age 
on myometrial contractility further.  They took uterine biopsies from the upper edge of the 
lower segment uterine incision from 62 women at the time of their elective caesarean section 
between 38 and 40 weeks’ gestation.  The myometrial tissue was dissected into longitudinal 
strips and examined in vitro for its inherent contractility.  They found a non-significant trend 
towards a reduction in frequency of spontaneous contractions in myometrial fibres with 
advancing maternal age.  Overall, they found a significant reduction in spontaneous 
contractile activity with maternal age and this effect persisted when the results were adjusted 
for advancing gestational age and number of previous vaginal deliveries.  The risk of operative 
vaginal delivery also increased linearly with maternal age in nulliparous women.  The rates of 
operative vaginal delivery in women < 35, 35-39 and > 40 years were 23.5%, 36.9% and 43% 
respectively. 
When the length of labour was examined in over 120,000 women who had a singleton, term, 
live, cephalic birth and who reached 10 cm dilatation for both nulliparous and multiparous 
women the duration of the first stage of labour decreased with advancing maternal age, and 
the duration of the second stage in nulliparous women increased with advancing maternal 
age. 
 
Perinatal death 
Perinatal death refers to the death of a fetus or a newborn in the perinatal period that 
commences at 24 completed weeks’ gestation and ends before seven completed days after 
birth.  It therefore includes stillbirth (antepartum and intrapartum) and early neonatal death.   
Stillbirth accounts for 67% of all perinatal deaths; excluding intrapartum causes, antepartum 
stillbirth accounts for 61% of all perinatal deaths and is by far the commonest cause of 
perinatal death at term.  Antepartum stillbirth is particularly important in women over 40 
years of age because they are less likely to have future pregnancies.  Female fecundity (the 
ability to produce offspring) declines with age, with monthly fecundity gradually decreasing 
from the mean age of 30 years onward.  If the mean rate of fecundity per cycle for women 
aged 20-30 years is scaled as 1, for a woman aged 33 years of age the relative rate is 0.75.  In 
addition to the reduction in natural fertility with increasing age, there is a significant decrease 
in the chance of having a healthy child after the age of 30.  Beyond 30 years of age the chance 
of a ‘healthy baby’ decreases by 3.5% each year.    Assisted reproductive technologies cannot 
entirely counteract nature, the live birth rate for IVF/ICSI among women less than 39 years is 
27.3% whereas for women aged between 40-42 years this rate is 11.1%, decreasing to 4% in 
women over 44 years of age. 
Maternal age 35 years and over is associated with a 65% increase in the odds of stillbirth and 
accounts for over 4000 stillbirths in high income countries each year. The increasing average 
age at first childbirth may be contributing to the static rates of antepartum stillbirth in the UK 
over the last 20 years.    One possible strategy to consider is an earlier induction of labour for 
women of advanced maternal age. 
 
Antepartum stillbirth 
Choosing the correct denominator 
Traditionally, the risk of perinatal death at term was expressed as the perinatal mortality rate 
(the number of all perinatal deaths divided by the number of births in a given week).  
However, when considering antepartum stillbirth, Smith et al suggest that the population of 
babies at risk at any given gestational week are not only the babies born that week, but all 
babies yet to be delivered.  Therefore it is important to consider the cumulative risk of 
stillbirth at any gestational age (the number of antepartum stillbirths at a given gestational 
week divided by the number of ongoing pregnancies at that gestational week). Although the 
perinatal mortality rate is lowest at 41 weeks, the gestational age associated with the lowest 
cumulative risk of perinatal death is 38 weeks.   
 
The risk of antepartum stillbirth at term 
The overall cumulative risk of antepartum stillbirth throughout gestation (from 20 to 41 
completed weeks) for women of all ages is 6.5 per 1000 pregnancies.  The cumulative risks of 
stillbirth for women younger than 35 years, 35-39 years and older than 40 years old, were 6.2, 
7.9, and 12.8 respectively. 
The largest increase in cumulative risk of stillbirth for women over 35 years of age starts at 39 
weeks and peaks at 41 weeks.  Women over 40 years old have a similar stillbirth risk at 39 
weeks as women who are between 25 and 29 years old at 41 weeks, and once they pass 40 
weeks’ gestation their risk of stillbirth exceeds that of all women < 40 years old at term. To 
quantify that risk, the risk of stillbirth between 37-41 weeks for women aged 35-39 years old 
is 1 in 382 ongoing pregnancies (RR 1.32), and for women 40 years or older 1 in 267 ongoing 
pregnancies (RR 1.88).  If this is expressed as a risk per 1000 ongoing pregnancies, 2.6 in 1000 
for women 35-39, and 3.7 in 1000 for women aged 40+, then comparisons with the routine 
practice of offering induction of labour postdates can be drawn, due to a 2-3 in 1000 risk of 
stillbirth for women of all ages. 
It is a widely accepted practice in the UK to offer induction of labour for a pregnancy that 
continues beyond 41 weeks, termed a postdates pregnancy.  This is because the rate of 
stillbirth increases six-fold from 0.35 per 1000 ongoing pregnancies at 37 weeks to 2.12 per 
1000 ongoing pregnancies at 43 weeks.  Neonatal (up to 28 days) and post neonatal (from 28 
days – 1 year of age) mortality falls significantly with advancing gestation up until 41 weeks, 
when it plateaus and then increases with prolonged pregnancy.  As such the overall risk of 
pregnancy loss (stillbirth plus death occurring up to the age of 1 year) increases 8 fold 
between 37 weeks and 43 weeks, justifying induction of labour at 41 weeks. 
Antepartum fetal monitoring 
 
An alternative solution to induction of labour at term for women of advanced maternal age 
at increased risk of late antepartum stillbirth, is to perform antepartum fetal surveillance.  
Could this alone identify those babies at increased risk of stillbirth, rendering induction of 
labour unnecessary? 
In a modelling comparison of 3 different strategies: a policy of usual care (no antepartum 
testing or induction of labour before 41 completed weeks), testing from 37 weeks with 
induction of labour for a positive test, and no testing with induction of labour at 41 weeks, 
there was a calculation of the number of antenatal tests, inductions of labour and caesarean 
sections that would arise and the number of fetal deaths that would be averted if each 
strategy was adopted.  The type of antepartum testing used was not specified. In the group 
with ‘normal management’, between 37 and 41 weeks, women aged over 35 years were 
modelled to experience 5.2 unexplained fetal deaths per 1000 pregnancies.  In the group with 
antepartum testing from 37 weeks with induction of labour for a positive result, 3.9 fetal 
deaths per 1000 would be avoided, but this would require 863 antepartum tests, 71 
inductions and 14 additional caesarean deliveries per fetal death averted.  A strategy of 
induction at 41 weeks would avert 0.9 fetal deaths per 1000 pregnancies and require 469 
inductions and 219 additional caesareans per fetal death averted.  The conclusion was that 
antepartum testing should be initiated over induction at 41 weeks. 
A retrospective cohort study of over 15,000 women who delivered at a single hospital in Los 
Angeles investigated surrogate markers of uteroplacental insufficiency in women 35 years of 
age and older, such as stillbirth, birth weight less than the 10th percentile, fetal distress, 
caesarean section for fetal distress, oligohydramnios, meconium passage and Apgar at 5 
minutes of less than 7, to see whether maternal age over 35 years was an independent risk 
factor for uteroplacental insufficiency. Of all the markers, two (intrapartum fetal distress and 
caesarean delivery for fetal distress) were significantly more common in the older cohort, but 
all other markers were the same in each cohort.  The increased risk of stillbirth in women of 
advanced maternal age could not be entirely explained by uteroplacental insufficiency, and 
there was deemed to be insufficient evidence to recommend routine antepartum fetal 
monitoring for all women over 35 years of age. 
Umbilical and fetal Doppler ultrasound is used widely as an antepartum surveillance tool to 
assess placental function and confirm fetal wellbeing.  Its use in pregnant women deemed to 
be ‘high’ and ‘low’ risk as a screening tool has been evaluated in Cochrane Reviews.  ‘High-
risk’ women are broadly defined as women who have either a medical condition such as 
diabetes, or a pregnancy-related condition such as antepartum haemorrhage which are 
associated with an increased perinatal morbidity or mortality.  In ‘high-risk’ women the use 
of Doppler ultrasound was associated with a statistically significant reduction in perinatal 
mortality (RR 0.71) and caesarean delivery (RR 0.90).  There was a non-statistically significant 
reduction in stillbirths, neonatal deaths and low Apgar scores.  The authors concluded that 
the use of Doppler ultrasound in high-risk women improved perinatal outcomes, without 
adversely effecting maternal outcomes.  A Cochrane review of the use of Doppler ultrasound 
in ‘low-risk’ women found no conclusive evidence that Doppler ultrasound confers fetal or 
maternal benefits.  If the small increased risk of antepartum stillbirth in women of advanced 
maternal age were largely due to placental insufficiency, then it is possible that Doppler 
ultrasound could provide a useful screening tool for detecting those women most at risk of 
stillbirth. 
 Aetiology of stillbirth in women of advanced maternal age 
 
Are particular causes of antepartum stillbirth more common in women of advanced maternal 
age? 
Traditional methods of classifying the cause of stillbirth (for example the Wigglesworth 
approach) leave two thirds of cases ‘unexplained’.  In 2008, CMACE, who report on perinatal 
deaths in the United Kingdom, introduced a new classification system which reduced the 
proportion of ‘unexplained’ stillbirths to 23%. They found the most common causes were 
haemorrhage (13%), intrauterine growth restriction (IUGR) (10%) and placental (9%).   They 
found that women aged 35 and over were less likely to experience a stillbirth due to IUGR.   
Twenty percent of stillbirths are associated with intra-uterine growth restriction.  Of those 
stillbirths where IUGR was a primary cause or contributing factor, 29% of cases occurred in 
women aged between 25-29 years old versus only 5% of cases occurring in women aged 40+ 
years.   Indeed, in an examination of whether the relationship between maternal age and 
unexplained stillbirth was due to an increased risk of IUGR in women of advanced maternal 
age, the stillborn infants of women aged over 35 years were found to be more likely to be 
normally grown than growth restricted.  This would suggest that antenatal screening with 
Doppler ultrasound for placental dysfunction in women of advanced maternal age may be 
ineffective. 
A study of 76 cases of unexplained antepartum stillbirth found that the chance of 
experiencing an unexplained stillbirth without IUGR increased by 16% for each year increase 
in maternal age. 
A study of 715 cases of stillbirth examined whether particular causes of stillbirth were more 
common in women aged 35 and over.  The authors found that stillbirths to women aged over 
35 were more likely to be due to infection, (odds ratio, OR 2.8), ‘unusual causes’ such as cord 
pathology (OR 2.0) or be ‘unexplained’ (OR 2.2).  Another study of 76 cases of unexplained 
antepartum stillbirth found that the chance of experiencing an unexplained stillbirth without 
IUGR increased by 16% for each year increase in maternal age. 
We performed an observational study using anonymised national data on 2850 cases of 
antepartum stillbirth in 2009 in the UK to breakdown the main causes of antepartum stillbirth 
by maternal age, and identify if specific causes are more common in older mothers.  We found 
that stillbirths in women aged 35 years and over are more likely to be due to major congenital 
anomalies (Relative Risk Ratio (RRR) 2.0, 95% CI 1.3-3.0), mechanical causes (RRR 1.6, 95% CI 
1.0-2.6), maternal disorders (RRR 2.1, 95% CI 1.2-3.6) or associated obstetric factors (RRR 2.1, 
95% CI 1.1-3.9) than women less than 35.  Women aged 35 years and over have a statistically 
significant increased risk of stillbirth due to major congenital anomalies (OR relative to live 
birth 1.6, 95% CI 1.3-1.9) and maternal disorders (OR 1.7, 95% CI 1.2-2.4) than younger 
women. Women aged 35 years and over were 30% more likely to experience a term stillbirth 
than women < 35 years (OR 1.3, 95% CI 1.1-1.5).  Stillbirth due to congenital anomaly was 
statistically significantly more likely in women ≥ 35 years. 
Advanced maternal age is a significant risk factor for antepartum stillbirth particularly at term.  
Attention should be given to stillbirth due to mechanical causes, maternal disorders and 
associated obstetric factors in such women.   
Lean et al  examined the placentas of a cohort of women of maternal age ≥ 35 years (96 
women) and a control group of younger women (aged 20-30 years, 47 women), all with 
uncomplicated pregnancies.  All women in the study delivered liveborn term infants weighing 
> 2.5 kg.  They found that the placentas of women of advanced maternal age displayed 
increased syncytial nuclear aggregates and decreased proliferation, and had increased amino 
acid transporter activity, all histological findings associated with stillbirths complicated by 
fetal growth restriction.  They also found a difference in placental hormones in women of 
AMA typically associated with placental dysfunction and stillbirth associated with fetal growth 
restriction, lower PAPP-A and soluble fms-like tyrosine kinase-1 (sFlt).  This study suggests 
that placental dysfunction may be more common in women of advanced maternal age and 
could be a contributor to their observed increased risk of stillbirth. 
Parity and stillbirth 
Are parous women of advanced maternal age at lower risk of antepartum stillbirth than 
nulliparous women? 
A large retrospective cohort study of over 600,000 women in Sweden found that nulliparous 
women were at a higher risk of stillbirth than multiparous women. 
In a large retrospective study of over 5 million deliveries across the USA between 2001 and 
2002, the relationship between parity, advanced maternal age and stillbirth was examined.  
While nulliparous and multiparous women had a similar increase in the risk of stillbirth with 
advancing maternal age, nulliparous women had a higher risk of stillbirth than multiparous 
women for all maternal age groups.  Thus the risk of stillbirth at 37 weeks per 1000 ongoing 
pregnancies in women aged <35, 35-39 and 40+ was 3.72, 6.41 and 8.65 in nulliparous women 
and 1.29, 1.99 and 3.29 in multiparous women. 
The contribution that parity plays to the risk of antepartum stillbirth in women of AMA has 
been extensively investigated.  It is fair to conclude that nulliparous women have a higher risk 
of stillbirth than multiparous women for all maternal age groups.   
Neonatal morbidity 
Much of the focus of the literature has been on the relationship between advanced maternal 
age and perinatal death.  Valent et al (2016) found an increased risk of a composite of 
neonatal morbidity associated with advanced maternal age; 35–39 years ARR 1.11, 40–44 
years 1.21, and 45–49 years 1.34 when the data was adjusted for factors known to increase 
the risk of neonatal morbidity. 
Women’s experience of pregnancy at an advanced maternal age 
An important study by Southby et al has examined women’s experience of pregnancy at 
advanced maternal age.  They performed one to one in-depth interviews with nulliparous 
women aged between 35 and 44 years old.  The central category identified by the authors 
was that women had a ‘now or never’ mentality and that concerns about their future 
opportunities to have more babies was the most important category affecting their 
experience of pregnancy.  We highly recommend this article to the reader. 
Management of advanced maternal age and pregnancy 
Reducing the risk of hypertensive disorders in pregnancy 
Maternal age 40 years of older constitutes a moderate risk factor for the development of pre-
eclampsia.  In the presence of one additional risk factor, NICE recommend that 75mg of 
aspirin should be prescribed from 12 weeks until delivery.  Given the increased risk of 
hypertensive disorders as with all pregnant women, care should be taken to offer advice on 
achieving a healthy lifestyle and the symptoms of pre-eclampsia and meticulous attention 
should be given to blood pressure and urinalysis for proteinuria at each antenatal visit. 
Surveillance for fetal growth restriction 
Maternal age 40 years or older constitutes a major risk factor for having a small-for-
gestational-age neonate and therefore serial ultrasounds for growth and umbilical artery 
Doppler from 26-28 weeks should be offered according to RCOG guidance. 
Consideration of induction of labour from 39 weeks’ gestation 
We conducted a randomised, controlled trial involving nulliparous women who were 35 years 
of age or older.  Women were randomly assigned to labour induction between 39 weeks 0 
days and 39 weeks 6 days of gestation or to expectant management (i.e., waiting until the 
spontaneous onset of labour or until the development of a medical problem that mandated 
induction). The primary outcome was caesarean delivery. The trial was not designed or 
powered to assess the effects of labour induction on stillbirth. The results showed that 
induction of labour at 39 weeks of gestation, as compared with expectant management, had 
no significant effect on the rate of caesarean section. Moreover, maternal and neonatal 
outcomes and women’s experience of childbirth did not differ significantly between the 
groups assigned to these strategies.  We performed an economic evaluation alongside the 
trial and found that the intervention was associated with a mean cost saving of £263 and a 
small additional gain in QALYs (though this was not statistically significant), even without 
considering any possible QALY gains from stillbirth prevention.  Consideration should be given 
to offering women of advanced maternal age induction of labour from 39 weeks’ gestation. 
Conclusion 
The average age of women at childbirth in industrialized nations has been increasing steadily 
for approximately 30 years.  Women aged 35 years or over have an increased risk of 
hypertensive disease, gestational diabetes, placenta praevia, placental abruption, perinatal 
death, preterm labour, fetal macrosomia and fetal growth restriction.  Unsurprisingly, rates 
of obstetrical intervention are higher among older women.  Of particular concern is the 
increased risk of antepartum stillbirth at term in women of advanced maternal age.  Women 
of advanced maternal age should be given to low dose aspirin (in the presence of an additional 
risk factor for pre-eclampsia), offered serial ultrasounds for fetal growth and wellbeing and 
induction of labour from 39 weeks gestation given the increased risk of antepartum stillbirth 
should be discussed with the woman. 
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Practice points 
 Maternal age 40 years of older constitutes a moderate risk factor for the development 
of pre-eclampsia.   
 Maternal age 40 years or older should be offered serial ultrasounds for growth and 
umbilical artery Doppler from 26-28 weeks. 
 Consideration should be given to offering women of advanced maternal age induction 
of labour from 39 weeks’ gestation. 
 
